Research and publications
More than 480 papers in international peer-reviewed journals, participation in multicentre clinical trials, and leadership of international guidelines in minimally invasive surgery.
Research that advances surgery and improves outcomes
Prof. Mohammad Abu Hilal takes part in many research projects and international studies in liver, pancreatic and biliary surgery and minimally invasive surgery. His research covers a wide range of topics, from developing surgical techniques and improving patient outcomes to defining the role of minimally invasive surgery in complex operations.
List of publications
The full list of his papers in peer-reviewed medical journals and chapters in scientific books (PDF)
Randomised controlled trials
Prof. Abu Hilal has taken part in a number of multicentre clinical trials and randomised studies, in collaboration with leading surgical and research centres around the world.
CAMINO
The role of MRI in detecting small colorectal cancer metastases
A trial to test the benefit of liver magnetic resonance imaging (MRI) compared with computed tomography (CT) in detecting small synchronous metastases of colorectal cancer. It is a multicentre study involving leading centres worldwide, and the hepatobiliary surgical and research team at Fondazione Poliambulanza, led by Prof. Abu Hilal, is one of its main pillars.
Published results: The Lancet Oncology, 2024 →DIPLOMA I
Minimally invasive versus open surgery for tumours of the pancreatic tail
A multicentre study of 258 patients from 30 international centres in the United States, Germany, France, Italy (Fondazione Poliambulanza, Brescia), the Netherlands and other countries. It compared minimally invasive and open distal pancreatectomy for tumours of the pancreatic tail in terms of oncological results, complications and recovery after surgery.
Published results: The Lancet Regional Health – Europe, 2023 →DIPLOMA II
Minimally invasive versus open Whipple procedure for tumours of the pancreatic head
An international randomised trial comparing laparoscopic or robotic pancreatoduodenectomy (the Whipple procedure) with open surgery in 288 patients at 14 specialist centres in six European countries; Prof. Abu Hilal was one of its principal investigators. Overall complication rates were similar with both approaches, while the minimally invasive group had a shorter hospital stay and fewer wound complications.
Published results: NEJM Evidence, 2025 →DIPLOMA II – 2x2
Robotic versus open Whipple procedure for pancreatic head cancer
An extension of DIPLOMA II: an international randomised trial comparing the robotic Whipple procedure with open surgery in patients with cancer of the pancreatic head or distal bile duct, designed to confirm that robotic surgery achieves equivalent oncological results (the rate of complete tumour removal). It includes 413 patients in 20 hospitals across seven countries.
Study protocol: Trials, 2026 →LIVACOR
Minimally invasive removal of the bowel tumour and liver metastases in one operation
A European multicentre randomised trial led by Fondazione Poliambulanza. It compares removing a colorectal tumour and its liver metastases in a single minimally invasive operation with performing the two operations separately in two stages, measuring functional recovery time after surgery and complication rates. Prof. Abu Hilal is one of the lead investigators of the trial.
Trial registration: ClinicalTrials.gov NCT05138094 →ORANGE SEGMENTS
Resection of the posterosuperior liver segments within an enhanced recovery programme
A prospective randomised trial comparing the clinical outcomes of laparoscopic and open surgery in patients undergoing resection of the posterosuperior segments of the liver within an enhanced recovery after surgery (ERAS) programme. The study enrolled 250 patients from several international centres.
Published results: The Lancet Regional Health – Europe, 2025 →ORANGE II PLUS
Laparoscopic versus open right or left hemihepatectomy
A randomised trial involving advanced national and international liver surgery centres in 7 countries, with 350 patients. It compared the clinical outcomes of minimally invasive and open liver surgery, specifically for resection of the left or right lobe of the liver.
Published results: Journal of Clinical Oncology, 2024 →RESTORE
Splenic autotransplantation and the immune response after pancreatic surgery
Because of the spleen’s importance to the immune system, the RESTORE randomised trial was designed to assess the immune response to splenic autotransplantation in patients undergoing distal pancreatectomy with splenectomy for pancreatic cancer. The study includes two groups: patients who received a splenic autotransplant, and patients who underwent spleen-preserving distal pancreatectomy. The immune response to a harmless vaccine is compared between the two groups.
Guidelines relied on worldwide
- The Southampton Consensus Guidelines for Laparoscopic Liver Surgery
- The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection
- Laparoscopic surgery for pancreatic neoplasms – EAES consensus, 2017
- European evidence-based guidelines on pancreatic cystic neoplasms, 2018
- Precision anatomy for minimally invasive surgery – Japan, 2021
Towards evidence-based surgery
Prof. Mohammad Abu Hilal continues to contribute to modern, evidence-based surgery, with a focus on improving clinical outcomes and strengthening the role of minimally invasive surgery in treating complex conditions.
Academic career